rs141282665
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001006658.3(CR2):āc.2445A>Gā(p.Gly815=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000528 in 1,614,106 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.00030 ( 1 hom., cov: 32)
Exomes š: 0.00055 ( 3 hom. )
Consequence
CR2
NM_001006658.3 synonymous
NM_001006658.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.191
Genes affected
CR2 (HGNC:2336): (complement C3d receptor 2) This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 1-207474945-A-G is Benign according to our data. Variant chr1-207474945-A-G is described in ClinVar as [Benign]. Clinvar id is 473098.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-207474945-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.191 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.000553 (808/1461800) while in subpopulation SAS AF= 0.00372 (321/86258). AF 95% confidence interval is 0.00339. There are 3 homozygotes in gnomad4_exome. There are 493 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CR2 | NM_001006658.3 | c.2445A>G | p.Gly815= | synonymous_variant | 14/20 | ENST00000367057.8 | NP_001006659.1 | |
CR2 | NM_001877.5 | c.2268A>G | p.Gly756= | synonymous_variant | 13/19 | NP_001868.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CR2 | ENST00000367057.8 | c.2445A>G | p.Gly815= | synonymous_variant | 14/20 | 1 | NM_001006658.3 | ENSP00000356024 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152188Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
45
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000685 AC: 172AN: 251112Hom.: 1 AF XY: 0.000906 AC XY: 123AN XY: 135704
GnomAD3 exomes
AF:
AC:
172
AN:
251112
Hom.:
AF XY:
AC XY:
123
AN XY:
135704
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000553 AC: 808AN: 1461800Hom.: 3 Cov.: 32 AF XY: 0.000678 AC XY: 493AN XY: 727210
GnomAD4 exome
AF:
AC:
808
AN:
1461800
Hom.:
Cov.:
32
AF XY:
AC XY:
493
AN XY:
727210
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000295 AC: 45AN: 152306Hom.: 1 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74478
GnomAD4 genome
AF:
AC:
45
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Immunodeficiency, common variable, 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at